Fig. 9From: Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokinesEffects of calipteryxin and (3’S,4’S)-3’,4’-disenecioyloxy-3’,4’-dihydroseselin on Ap-1-DNA binding activity (a) and c-Jun (b) protein expressionBack to article page